General
Oxford-AstraZeneca, local COVID vaccines given urgent approval in India
The head of India’s drugs regulator said he had given final approval for the emergency use of two coronavirus vaccines, one developed by AstraZeneca and Oxford University and the other by local company Bharat Biotech.
Key points:
- India’s pharmaceutical regulator approved two COVID-19 vaccines simultaneously
- The Australian Government has ordered 50 million doses of the Oxford-AstraZeneca vaccine
- India’s first round of vaccinations aims to immunise 300 million people against coronavirus
The overall efficacy of the Oxford-AstraZeneca vaccine was 70.42 per cent, while Bharat Biotech’s COVAXIN was “safe and provides a robust immune response”, Drugs Controller General of India, Venugopal G Somani, said.
The British-developed Oxford-AstraZeneca…
-
Noosa News13 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
Noosa News16 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General12 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News21 hours agoManjimup engineer turns previously wasted avocados into liquid gold